Matthias Mattke

Dr. Matthias Mattke


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 September 2022 in Strahlentherapie und Onkologie
Verified
Journal Article
Open access
PDF file
MMMatthias Mattke
Matthias Mattke
MOMatteo Ohlinger
Matteo Ohlinger
NBNina Bougatf
Nina Bougatf
SHSemi Harrabi
Semi Harrabi
RWRobert Wolf
Robert Wolf
JDJürgen Debus
Jürgen Debus
Background: This study aimed to compare the results of irradiation with protons versus irradiation with carbon ions in a raster scan technique in patients with skull base chordomas and to identify risk factors that may compromise treatment results. Methods: A total of 147 patients (85 men, 62 women) were irradiated with carbon ions (111 patients) or protons (36 patients) with a median dose of 66 Gy (RBE (Relative biological effectiveness); carbon ions) in 4 weeks or 74 Gy (RBE; protons) in 7 weeks at the Heidelberg Ion Beam Therapy Center (HIT) in Heidelberg, Germany. The median follow-up time was 49.3 months. All patients had gross residual disease at the beginning of RT. Compression of the brainstem was present in 38%, contact without compression in 18%, and no contact but less than 3 mm distance in 16%. Local control and overall survival were evaluated using the Kaplan–Meier Method based on scheduled treatment (protons vs. carbon ions) and compared via the log rank test. Subgroup analyses were performed to identify possible prognostic factors. Results: During the follow-up, 41 patients (27.9%) developed a local recurrence. The median follow-up time was 49.3 months (95% CI: 40.8–53.8; reverse Kaplan–Meier median follow-up time 56.3 months, 95% CI: 51.9–60.7). No significant differences between protons and carbon ions were observed regarding LC, OS, or overall toxicity. The 1‑year, 3‑year, and 5‑year LC rates were 97%, 80%, and 61% (protons) and 96%, 80%, and 65% (carbon ions), respectively. The corresponding OS rates were 100%, 92%, and 92% (protons) and 99%, 91%, and 83% (carbon ions). No significant prognostic factors for LC or OS could be determined regarding the whole cohort; however, a significantly improved LC could be observed if the tumor was > 3 mm distant from the brainstem in patients presenting in a primary situation. Conclusion: Outcomes of proton and carbon ion treatment of skull base chordomas seem similar regarding tumor control, survival, and toxicity. Close proximity to the brainstem might be a negative prognostic factor, at least in patients presenting in a primary situation.

1 February 2025 in Cancers
Verified
Journal Article
Open access
PDF file
SVSara Vockner
Sara Vockner
MMMatthias Mattke
Matthias Mattke
IMIvan Michael Messner
Ivan Michael Messner
CGChristoph Gaisberger
Christoph Gaisberger
Franz ZehentmayrFranz Zehentmayr
Franz Zehentmayr
MSMarkus Stana
Markus Stana
Artificial Intelligence (AI) applications are increasingly prevalent in radiotherapy, including commercial software solutions for automatic segmentation of anatomical structures for 3D Computed Tomography (CT). However, their use in intraoperative electron radiotherapy (IOERT) remains limited. In particular, no AI solution is available for contouring cone beam CT (CBCT) images acquired with a mobile CBCT device. The U-Net convolutional neural network architecture has gained huge success for medical image segmentation but still has difficulties capturing the global context. To increase the accuracy in CBCT segmentation for IOERT, three different AI architectures were trained and evaluated. The features of the natural language processing models Transformer and xLSTM were added to the popular U-Net architecture and compared with the standard U-Net and manual segmentation performance. These networks were trained and tested using 55 CBCT scans obtained from breast cancer patients undergoing IOERT in the department of radiotherapy and radiation oncology in Salzburg, and each architecture’s segmentation performance was assessed using the dice coefficient (DSC) as a similarity measure. The average DSC values were 0.83 for the standard U-Net, 0.88 for the U-Net with transformer features, and 0.66 for the U-Net with xLSTM. The hybrid U-Net architecture, including Transformer features, achieved the best segmentation accuracy, demonstrating an improvement of 5% on average over the standard U-Net, while the U-Net with xLSTM showed inferior performance compared to the standard U-Net. With the help of automatic contouring, synthetic CT images can be generated, and IOERT challenges related to the time-consuming nature of 3D image-based treatment planning can be addressed.

8 February 2024 in Cancers
Verified
Journal Article
Open access
PDF file
MMMatthias Mattke
Matthias Mattke
MOMatteo Ohlinger
Matteo Ohlinger
NBNina Bougatf
Nina Bougatf
RWRobert J Wolf
Robert J Wolf
TWThomas Welzel
Thomas Welzel
Semi B HarrabiSemi B Harrabi
Semi B Harrabi
Background: The current study aims to evaluate the occurrence of temporal lobe reactions and identify possible risk factors for patients who underwent particle therapy of the skull base. Methods: 244 patients treated for skull base chordoma (n = 144) or chondrosarcoma (n = 100) at the Heidelberg Ion Beam Therapy Center (HIT) using a raster scan technique, were analyzed. Follow-up MRI-scans were matched with the initial planning images. Radiogenic reactions were contoured and analyzed based on volume and dose of treatment. Results: 51 patients with chordoma (35.4%) and 30 patients (30%) with chondrosarcoma experienced at least one temporal lobe reaction within the follow-up period (median 49 months for chondrosarcoma, 62 months for chordoma). Age, irradiated volume, and dose values were significant risk factors for the development of temporal lobe reactions with the highest significance for the value of DMax-7 being defined as the dose maximum in the temporal lobe minus the 7cc with the highest dose (p = 0.000000000019; OR 1.087). Conclusion: Temporal lobe reactions are a common side effect after particle therapy of the skull base. We were able to develop a multivariate model, which predicted radiation reactions with a specificity of 99% and a sensitivity of 52.2%.

1 August 2024 in Journal of Gastrointestinal Oncology
Verified
Journal Article
Open access
PDF file
MMMatthias Mattke
Matthias Mattke
Review Article Particle therapy in gastrointestinal cancer—a narrative review Matthias Mattke

5 November 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
MSMarkus Stana
Markus Stana
KEKlarissa Ellmauer
Klarissa Ellmauer
SVSara Vockner
Sara Vockner
IMIvan Michael Messner
Ivan Michael Messner
GFGerd Fastner
Gerd Fastner
MMMatthias Mattke
Matthias Mattke
Background/Objectives: Accurate characterization of treatment geometry is essential for intraoperative electron radiotherapy (IOeRT) treatment planning. Mobile cone-beam computed tomography (CBCT) enables volumetric assessment of intraoperative anatomy beyond conventional point-based measurements. This study compared clinically applied distance measurement techniques with geometric distance descriptors retrospectively extracted from comprehensive three-dimensional CBCT datasets. Methods: Ninety-six patients receiving IOeRT as a tumor-bed boost during breast-conserving surgery were included. Manual CBCT measurements (mCBCT) were compared with mean (USavg) and minimum (USmin) ultrasound measurements per patient. Comprehensive 3D distance extraction was performed in 82 CBCT datasets using an approximated thoracic-wall surface as the geometric reference. Minimum and first-quartile distances were evaluated across the complete applicator cross-section and within a 1-cm-diameter inner disk around the central beam axis. Results: The mean paired difference between mCBCT and USavg was 0.3 mm and was not statistically significant, whereas mCBCT measurements exceeded USmin by an average of 1.5 mm. In the principal comparison, the minimum CBCT-derived distance within the inner disk was 1.4 mm smaller than mCBCT. Across the complete applicator area, minimum distances were 9.1-10.7 mm smaller than the clinical measurements. The first-quartile distance across all surface points was 1.4 mm smaller than mCBCT, whereas the corresponding inner-disk difference was not statistically significant after correction. Isodose-atlas-based dose-volume analysis indicated that a 1.5-mm change in assumed penetration depth could correspond to an approximately 7% change in the 90% isodose volume at shallow depths. Conclusions: Clinical CBCT and ultrasound measurements showed small group-level differences but substantial patient-level variability. Comprehensive 3D CBCT analysis revealed spatial variations in tissue depth not fully represented by the clinical measurements, highlighting the limitations of characterizing treatment geometry using a single distance. Although anatomical accuracy and patient-specific dosimetric consequences remain to be established, these findings support the potential of intraoperative 3D CBCT to advance IOeRT toward individualized, image-guided treatment planning.